Raymond James analyst Michael Rose downgraded Amerant Bancorp (AMTB) to Market Perform from Outperform without a price target The company’s Q1 results fell short of forecasts on a core earnings basis as credit headwinds are persisting, the analyst tells investors in a research note. The firm is stepping to the sideline given the quarter’s “negative migration.” Coupled with an uncertain backdrop in light of tariffs and other policy changes out of the Trump administration and a reduction in its loan growth outlook, “a wait and see approach is now warranted” for Amerant, contends Raymond James.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMTB: